Subsidiaries and Holdings

We are constantly expanding our capacities to accommodate increasing requirements and new markets. We currently hold shares in three subsidiaries:

oncomed manufacturing a.s.

oncomed was founded in 2010 as a new production facility in Brno (Czech Republic). Modern production capacities for the manufacture and development of sterile cytostatic and oncogeneric drugs meet current requirements and the demands of future markets. The “full service” provided covers all the individual steps of contract manufacturing, from development to comprehensive validation procedures right up to the packaging design.

ONCOTEC Pharma Produktion GmbH

Since 1997, Oncotec has been a reliable global partner in the manufacture and development of aseptically produced cytostatics. The particular advantage here is that Oncotec provides a full service if required and is the contact partner for the entire added-value chain, from development at a laboratory level to scaling up and then to market launch and commercial production.


medac s.a.s
23 rue Pierre Gilles de Gennes
69007 Lyon, France
phone: +33 (0)4 37661470
fax: +33 (0)4 37662878
mail: contact(at)


medac Pharma S.r.l.
Via Viggiano, 90
00178 Rome, Italy
phone: +39 06 51 59 12 1
fax: +39 06 51 59 12 20
mail: info(at)


medac Pharma LLP.
Scion House
Stirling University Innovation Park
Stirling FK9 4NF, UK
phone: +44 (0)1786 458086
fax: +44 (0)1786 458032
mail: info(at)


nippon medac Co., Ltd.
3F, Nihonbashi-Nakaya Bldg.
12-12, Nihonbashi-kobunacho
Chuo-ku, Tokyo 103-0024
phone: +81 (0)3 6661-6270
fax: +81 (0)3 6661-6271